BeyondSpring Inc. Stock News
$2.35
25.67%
day before yesterday
Nasdaq,
Dec 19, 10:16 pm CET
BeyondSpring Inc. Stock News
Neutral
GlobeNewsWire
●
9 days ago
FLORHAM PARK, N.J., Dec. 12, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a clinical-stage biopharmaceutical company developing first-in-class immune-modulating cancer therapies, today announced results from the Asian subset (n=488) of its global Phase 3 DUBLIN-3 trial evaluating Plinabulin plus docetaxel compared to docetaxel alone in second- or third-line EGFR wild-type non-smal...
Neutral
Seeking Alpha
●
3 months ago
BeyondSpring Inc. (NASDAQ:BYSI ) 2025 Annual Shareholders Meeting Call September 15, 2025 9:00 AM EDT Company Participants Lan Huang - Co-Founder, Chairman & CEO Presentation Unknown Attendee Good morning, and welcome to the 2025 Annual Meeting of Shareholders of BeyondSpring Inc. Lan Huang Co-Founder, Chairman & CEO Good morning. I'm Lan Huang, Chair of Board of Directors and Chief Executive O...
Neutral
GlobeNewsWire
●
6 months ago
FLORHAM PARK, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) today announced publication of a human clinical study in Med (Cell Press) demonstrating that Plinabulin, when combined with radiation and a checkpoint inhibitor, induces dendritic cell (DC) maturation and elicits tumor responses in patients across multiple cancer types who had failed prior ICI therapy. The st...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
